Myeloid-Derived Itaconate Suppresses Antitumor Immunity
- PMID: 36484538
- DOI: 10.1158/2159-8290.CD-RW2022-213
Myeloid-Derived Itaconate Suppresses Antitumor Immunity
Abstract
Itaconate secreted by MDSCs suppresses CD8+ T-cell effector function and promotes tumor growth.
©2023 American Association for Cancer Research.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
